The 20th International Collateral Congress was held in Shijiazhuang

[ad_1]

On February 24, the 20th International Collateral Disease Congress with the theme of “Inheritance, Innovation, Openness, and Integration” was held in Shijiazhuang City.

The conference focused on the theory of collateral disease to guide the prevention and treatment of cardiovascular and cerebrovascular diseases, diabetes, respiratory diseases and other diseases, as well as related drug development and clinical research. The conference exchanged and shared the latest scientific research results of collateral disease research, and fully promoted the inheritance, innovation and development of collateral disease, and promoted traditional Chinese medicine. High-quality development and promotion of academic exchanges and cooperation on traditional Chinese medicine at home and abroad.

Nearly 20 academicians from the two academies and more than 100,000 medical experts and scholars from home and abroad gathered at the conference online and offline.Photo courtesy of Yiling Pharmaceutical

Professor Wu Yiling, an academician of the Chinese Academy of Engineering, combined the holistic thinking of traditional Chinese medicine with modern technology to systematically construct three major theoretical frameworks for the study of collateral diseases – “collateral disease syndrome and treatment”, “venation theory” and “qi collateral theory”, forming a guide for cardiovascular and cerebrovascular diseases. and systematic original theories of neurological, endocrine, and immune diseases. At present, collateral disease of traditional Chinese medicine has become a key discipline and a dominant discipline of the State Administration of Traditional Chinese Medicine, forming a new model of academic innovation and transformation of traditional Chinese medicine integrating “theory + clinical + new drugs + experiments + evidence-based”.

“As a model of traditional Chinese medicine inheritance and innovation, the theory of collateral disease has made fruitful achievements in improving patient clinical benefits and developing innovative drugs after 40 years of hard work and innovation with the joint efforts of domestic and foreign experts represented by Academician Wu Yiling. The results also summarize the successful experience of putting theory first and evidence-based as king.” Zhang Boli, an academician of the Chinese Academy of Engineering, said in his speech at the opening ceremony that he hopes to continue to adhere to the purposes of inheritance, openness, innovation, and integration in the future and actively promote the development of traditional Chinese medicine. Inherit innovation and development, and contribute to promoting the modernization and internationalization of traditional Chinese medicine.

Wu Zhendou, director of the International Cooperation Department of the State Administration of Traditional Chinese Medicine, said that as a unique component of the theoretical system of traditional Chinese medicine, collateral disease has made fruitful achievements in theoretical innovation and drug research and development in recent years. The International Congress of Collateral Medicine has become an important platform to promote academic exchanges and mutual learning of traditional Chinese medicine at home and abroad. It is hoped that the majority of TCM workers will have extensive exchanges and in-depth discussions, give full play to the advantages and characteristics of collateral disease, strengthen scientific and technological innovation, expand industrial collaboration, and promote collateral disease to contribute more to the inheritance, innovation and development of traditional Chinese medicine and the construction of a healthy China.

“In 2005, the China Association of Traditional Chinese Medicine founded the International Congress of Collateral Diseases. In the past 20 years, the conference has always focused on the needs of national strategic development and major scientific issues of traditional Chinese medicine, and has built an academic exchange platform for domestic and foreign experts and scholars. There has been a trend inside and outside the industry of learning, inheriting, and applying the theory of collateral disease.” Wang Guochen, vice president and secretary-general of the Chinese Society of Traditional Chinese Medicine, said that in the future, the society will create more international brand conferences on traditional Chinese medicine and carry out A variety of academic exchange activities share the progress of academic and clinical research on traditional Chinese medicine, thereby promoting the inheritance, innovation and open development of traditional Chinese medicine.

At the main forum of this conference, academicians Wu Yiling, Zhang Yun, Yu Jinming, Ge Junbo, and Jia Weiping of the two academies gave speeches titled “Construction of the Theoretical System of Collateral Disease and Its Transformation and Application” and “Twenty Years of Research on Tongxinluo’s Anti-atherosclerosis” respectively. “New Strategies for Precision Prevention and Treatment of Tumors”, “Pan-vascular Diseases: Enlightenment and Future Strategies”, and “Epidemiology and Prevention Strategies of Chronic Complications of Diabetes in China” academic reports, focusing on the transformation of innovative results of collateral disease theory and the application of collateral disease theory in many Conduct in-depth exchanges on the value of disease prevention and treatment in the field of disease.

At the same time, Professor Jia Zhenhua from the Hebei Institute of Integrated Traditional Chinese and Western Medicine, Professor Yang Yuejin from Fuwai Hospital of the Chinese Academy of Medical Sciences, Professor Huang Congxin from Wuhan University People’s Hospital, Professor Li Xinli from the First Affiliated Hospital of Nanjing Medical University, and Professor Dong Qiang from Huashan Hospital Affiliated to Fudan University also joined forces I have made relevant academic reports on my clinical work, discussing the prevention and treatment of respiratory diseases by Lianhua Qingwen Capsules and Lianhua Qingke Tablets, Tongxinluo Capsules for the treatment of myocardial infarction, Shensong Yangxin Capsules for the prevention and treatment of arrhythmia, Qi Li Qiangxin Capsule plays an important role in the treatment of chronic heart failure and Tongxinluo in the prevention and treatment of stroke.

In addition, the conference also set up a coronary heart disease forum, arrhythmia forum, heart failure forum, cerebrovascular disease forum, diabetes forum, respiratory forum, urology forum, tumor forum, medical and health development forum, and primary health and high-quality service development forum. , anti-aging forum and other forums, many academicians and medical experts participating in the meeting conducted in-depth discussions on how the theory of collateral disease can serve public health in various disease fields.

[ad_2]

Source link